Azitra (NYSEAMERICAN:AZTR) Announces Earnings Results

Azitra (NYSEAMERICAN:AZTR) announced its earnings results on Tuesday. The company reported ($0.17) earnings per share for the quarter, topping the consensus estimate of ($0.48) by $0.31, Zacks reports.

Azitra Stock Performance

NYSEAMERICAN:AZTR traded down $0.04 during mid-day trading on Thursday, reaching $0.45. The stock had a trading volume of 252,599 shares, compared to its average volume of 888,739. The company has a debt-to-equity ratio of 0.01, a quick ratio of 0.77 and a current ratio of 0.77. Azitra has a twelve month low of $0.43 and a twelve month high of $68.40.

About Azitra

Azitra, Inc, an early-stage biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It develops ATR-12, a genetically modified strain of S. epidermidis, which is in Phase Ib clinical trial for treating Netherton syndrome, a skin disease.